Invesco Exchange-Traded Fund Trust II has released its latest financial report, revealing total assets of approximately $25.26 million and net assets of around $21.07 million as of August 31, 2026. This update is significant as it underscores the company's ongoing commitment to transparency and regulatory compliance within the investment management sector.
The filing, submitted on October 30, 2026, is part of Invesco's regular disclosures to the Securities and Exchange Commission (SEC). The company has been active in maintaining its reporting obligations, with several recent filings, including multiple NPORT-P forms submitted on the same day, indicating a robust reporting strategy.
Background
Invesco Exchange-Traded Fund Trust II is an investment entity focused on managing exchange-traded funds (ETFs). The company is identified by the Central Index Key (CIK) number 0001378872. It operates under the SEC file number 811-21977 and has a fiscal year ending on October 31. The trust has undergone name changes in the past, previously known as PowerShares Exchange-Traded Fund Trust II and PowerShares Global Exchange-Traded Fund Trust.
What the Filing Says
The recent filing indicates that as of August 31, 2026, Invesco's total assets were reported at $25,258,902.62, with total liabilities of $4,190,560.98, resulting in net assets of $21,068,341.64. The report also detailed the fund's investment strategy, including its holdings in various securities.
Impact
This filing may affect investors and stakeholders in the investment management industry, particularly those interested in ETFs and the performance of Invesco's funds. The reported figures provide insights into the company's financial health and operational strategies, which may influence investor confidence and market dynamics.
What's Next
The filing does not say what happens next. However, continued monitoring of Invesco's financial disclosures will be essential for stakeholders to assess the company's performance and strategic direction in the competitive ETF landscape.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






